Patrizio Pasquale, Sanguineti Fabio, Sakkas Denny
Yale University Fertility Center, 150 Sargent Drive, New Haven, CT 06511, USA.
Ann N Y Acad Sci. 2008 Apr;1127:59-63. doi: 10.1196/annals.1434.021.
A male factor is implicated in about 50% of couples treated with advanced assisted reproductive techniques (in vitro fertilization [IVF] or intracytoplasmic sperm injection [ICSI]). An important function of spermatozoa is to deliver the paternal genome to the oocyte. However, neither the routine testing of male fertility potential, nor its treatment, addresses the specific mechanisms by which spermatozoal factors may impact reproductive outcome. Recently, a number of screening tests for DNA integrity have been proposed to assess sperm chromatin abnormalities. These include nonspecific DNA strand breaks, numerical abnormalities in spermatozoal chromosome content, and alterations in the epigenetic regulation of the paternal genome. This minireview discusses methods to assess the influence of the paternal genome on reproduction beyond that which can be appreciated by simple quantitative and morphologic evaluation of spermatozoa. Finally, new data on how to select the "best fit" sperm for ICSI will be presented.
在接受先进辅助生殖技术(体外受精[IVF]或卵胞浆内单精子注射[ICSI])治疗的夫妇中,约50%存在男性因素问题。精子的一项重要功能是将父本基因组传递给卵母细胞。然而,无论是对男性生育潜力的常规检测,还是其治疗,都未涉及精子因素可能影响生殖结果的具体机制。最近,已提出多项用于评估DNA完整性的筛查测试,以检测精子染色质异常。这些异常包括非特异性DNA链断裂、精子染色体含量的数值异常,以及父本基因组表观遗传调控的改变。本综述讨论了评估父本基因组对生殖影响的方法,这些影响超出了通过简单的精子定量和形态学评估所能认识到的范围。最后,还将介绍有关如何为ICSI选择“最适合”精子的新数据。